Relationship between response to aripiprazole once-monthly and paliperidone palmitate on work readiness and functioning in schizophrenia: A post-hoc analysis of the QUALIFY study

• Steven G. Potkin ,

  * E-mail: sgpotkin@uci.edu

  Affiliation Department of Psychiatry and Human Behavior, University of California, Irvine, California, United States of America

  ⨯
• Jean-Yves Loze,

  Affiliation Otsuka Pharmaceutical Europe Limited., Wexham, United Kingdom

  ⨯
• Carlos Forray,

  Affiliation Lundbeck LLC, Paramus, New Jersey, United States of America

  ⨯
• Ross A. Baker,

  Affiliation Otsuka Pharmaceutical Development & Commercialization, Inc., Princeton, New Jersey, United States of America

  ⨯
• Christophe Sapin,

  Affiliation Lundbeck SAS, Issy-les-Moulineaux, France

  ⨯
• Timothy Peters-Strickland,

  Affiliation Otsuka Pharmaceutical Development & Commercialization, Inc., Princeton, New Jersey, United States of America

  ⨯
• Maud Beillat,

  Affiliation Lundbeck SAS, Issy-les-Moulineaux, France

  ⨯
• Anna-Greta Nylander,

  Affiliation H. Lundbeck A/S, Valby, Denmark

  ⨯
• Peter Hertel,

  Affiliation H. Lundbeck A/S, Valby, Denmark

  ⨯
• Simon Nitschky Schmidt,

  Affiliation H. Lundbeck A/S, Valby, Denmark

  ⨯
• Anders Ettrup,

  Affiliation H. Lundbeck A/S, Valby, Denmark

  ⨯
• Anna Eramo,

  Affiliation Lundbeck LLC, Deerfield, Illinois, United States of America

  ⨯
• Karina Hansen,

  Affiliation Lundbeck SAS, Issy-les-Moulineaux, France

  ⨯
• Dieter Naber

  Affiliation Department of Psychiatry and Psychotherapy, University Medical Center Hamburg-Eppendorf, Hamburg, Germany

  ⨯